Book an appointment

🇦🇺 From Australia · Cardiology · Cardiac surgery

Coronary disease treatment in China for Australia patients

End-to-end pathway: visa, flight, hospital match, cost and length of stay — tailored for patients travelling from Australia for coronary disease care.

← Full Coronary disease guide

Pathway at a glance

Visa
M-Visa (Medical Visa)
Processing
5–10 business days
Flight
10–12 hours (SYD/MEL to PEK/PVG)
Time zone
2–3 hours behind (Sydney) — same day arrival possible
Language
Strong English at all major Class A international departments
China cost (USD)
22,000–35,000

About coronary disease

Coronary artery disease is the leading cause of death globally and accumulates risk over decades. Modern care spans primary prevention (statins, BP control, lifestyle), secondary prevention after events, and intervention (PCI, CABG). China's cardiac centres — anchored by Fuwai NCCD with one of the highest cardiac surgery volumes globally — deliver world-class care at substantially lower cost.

Why Australia patients travel to China

Australian patients commonly come for: orthopedic surgery (Medicare elective wait), stem cell therapy (TGA-restricted at home), cancer treatment (CAR-T, proton), dental tourism, and high-end executive physicals. Direct flights from major cities to Beijing/Shanghai.

Recommended cities for Australia patients

Shanghai (cardiology, orthopedic, oncology) and Beijing (PUMC) for major cases. Hong Kong / Shenzhen route popular for stem cell, dental and shorter trips.

Diagnostic workup at Class A centres

  • Comprehensive lipid panel including ApoB and (once in lifetime) Lp(a)
  • HbA1c, fasting glucose, BP measurement
  • ECG; echocardiogram in selected patients
  • Coronary artery calcium (CAC) score for intermediate-risk patients
  • Coronary CT angiography (CTA) for symptomatic patients
  • Stress imaging or coronary angiography in advanced cases

Workup cost band: $280–$540 USD.

Treatment options

Lifestyle modification

first-line

Diet, exercise, sleep, smoking cessation — foundational across all stages.

Statin therapy

first-line

First-line lipid-lowering. PCSK9 inhibitors and ezetimibe for higher-risk or insufficiently controlled patients.

Antiplatelet therapy

first-line

Aspirin, P2Y12 inhibitors per indication.

Percutaneous coronary intervention (PCI)

selected cases

Stenting for acute coronary syndromes, refractory angina with appropriate anatomy. Drug-eluting stents standard.

Coronary artery bypass grafting (CABG)

selected cases

Surgical revascularisation for left main disease, three-vessel disease (especially with diabetes or reduced LV function), and selected complex cases. Off-pump and minimally invasive options available.

Learn more →

Cardiac rehabilitation

first-line

Strong evidence for mortality and morbidity reduction post-event. Available at academic cardiac centres.

Procedure cost from Australia

ProcedureChina (USD)Australia (USD)Length of stay
CABG22,000 – 35,00045,000 – 70,00021–28 d

Visa pathway for Australia patients

Long Medicare wait times for elective surgery (knee/hip replacement, cataract) drive substantial Australian medical tourism to China. AUD purchasing power is favourable.

  1. 1

    Receive invitation letter

    Panda Touring Care issues hospital invitation letter within 3–5 business days.

  2. 2

    Complete COVA online

    Fill at cova.cs.mfa.gov.cn. Print and sign.

  3. 3

    Submit at CVASC

    Canberra, Sydney, Melbourne, Brisbane, or Perth visa centre with biometrics.

  4. 4

    Collect visa

    5–10 business days standard. Express 2–3 days.

Full Australia → China visa guide →

Frequently asked

Do Australia patients need a visa for coronary disease treatment in China?
Yes — Australia citizens require M-Visa for medical treatment in China. Processing: 5–10 business days. Fee: AUD $109.50 standard · +AUD $80 expedited. Validity: Up to 3 years multi-entry possible.
How long is the flight from Australia to China?
10–12 hours (SYD/MEL to PEK/PVG)
Which Chinese cities are best for Australia patients seeking coronary disease care?
Shanghai (cardiology, orthopedic, oncology) and Beijing (PUMC) for major cases. Hong Kong / Shenzhen route popular for stem cell, dental and shorter trips.
How much can Australia patients save on coronary disease treatment in China?
Typical Class A all-in pricing in China: $22,000–$35,000 USD. Equivalent in Australia: $45,000–$70,000 USD. Savings before travel: roughly 22–69%.
What's the diagnostic workup for coronary disease at Class A international departments?
Comprehensive lipid panel including ApoB and (once in lifetime) Lp(a); HbA1c, fasting glucose, BP measurement; ECG; echocardiogram in selected patients; Coronary artery calcium (CAC) score for intermediate-risk patients; Coronary CT angiography (CTA) for symptomatic patients; Stress imaging or coronary angiography in advanced cases.

Plan your coronary disease treatment from Australia

We arrange visa support, hospital match, written quote and door-to-door logistics from Australia. No obligation.

Request a quote Visa details